1. Home
  2. NBN vs WVE Comparison

NBN vs WVE Comparison

Compare NBN & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NBN
  • WVE
  • Stock Information
  • Founded
  • NBN 1872
  • WVE 2012
  • Country
  • NBN United States
  • WVE Singapore
  • Employees
  • NBN N/A
  • WVE N/A
  • Industry
  • NBN Major Banks
  • WVE Biotechnology: Pharmaceutical Preparations
  • Sector
  • NBN Finance
  • WVE Health Care
  • Exchange
  • NBN Nasdaq
  • WVE Nasdaq
  • Market Cap
  • NBN 811.6M
  • WVE 915.6M
  • IPO Year
  • NBN N/A
  • WVE 2015
  • Fundamental
  • Price
  • NBN $95.69
  • WVE $7.11
  • Analyst Decision
  • NBN Hold
  • WVE Strong Buy
  • Analyst Count
  • NBN 1
  • WVE 16
  • Target Price
  • NBN $115.00
  • WVE $20.19
  • AVG Volume (30 Days)
  • NBN 95.3K
  • WVE 1.8M
  • Earning Date
  • NBN 10-28-2025
  • WVE 11-11-2025
  • Dividend Yield
  • NBN 0.04%
  • WVE N/A
  • EPS Growth
  • NBN 32.98
  • WVE N/A
  • EPS
  • NBN 10.08
  • WVE N/A
  • Revenue
  • NBN $204,086,000.00
  • WVE $93,946,000.00
  • Revenue This Year
  • NBN $17.75
  • WVE N/A
  • Revenue Next Year
  • NBN $9.91
  • WVE $6.85
  • P/E Ratio
  • NBN $9.48
  • WVE N/A
  • Revenue Growth
  • NBN 33.67
  • WVE N/A
  • 52 Week Low
  • NBN $75.29
  • WVE $5.28
  • 52 Week High
  • NBN $113.01
  • WVE $16.74
  • Technical
  • Relative Strength Index (RSI)
  • NBN 35.11
  • WVE 41.44
  • Support Level
  • NBN $93.45
  • WVE $6.91
  • Resistance Level
  • NBN $111.22
  • WVE $7.24
  • Average True Range (ATR)
  • NBN 3.07
  • WVE 0.31
  • MACD
  • NBN -1.65
  • WVE 0.06
  • Stochastic Oscillator
  • NBN 10.84
  • WVE 58.69

About NBN Northeast Bank

Northeast Bank provides banking and financial services to individual and corporate customers in the United States. The firm conducts its loan-related activities through two primary channels: the Community Banking Division, and the Small Business Administration (SBA) National Division. Its loan portfolio comprises residential mortgage loans; multi-family and other commercial real estate loans; commercial and industrial loans, consumer loans, and small business administration loans. The firm also provides telephone banking, online banking, mobile banking, and remote deposit capture services. The revenue of the company is derived principally from interest and dividends from the bank.

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

Share on Social Networks: